Skip to main content

Study M801

Study name

Zacharias HU 2021

Title

A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression

Overall design

The aim of this study was to conduct a metabolome-wide association analysis to investigate the link between the serum metabolome and depressed mood in 1411 participants of the KORA F4 study (discovery cohort). Three categories, 'no', 'other', and 'major depressive symptoms' were defined for the KORA F4 discovery cohort if 2-4 or at least 5 of the PHQ-9 questions had been answered with at least 'more than half of the days' in the past two weeks, and one of the diagnosed symptoms was depressed mood or anhedonia. For the KORA F4 study, 72 participants suffering from depressed mood (depression group). Serum metabolomics data comprised 353 unique metabolites measured by Metabolon. The authors found significantly lower laurylcarnitine levels in KORA F4 participants with depressed mood after multiple testing correction according to Benjamini/Hochberg. This finding was replicated in the independent SHIP-Trend study (968 study participants). For the Ship-Trend baseline cohort, 52 participants were diagnosed with depressed mood (depression group). A targeted metabolic profiling approach for the plasma specimens was carried out based on the SHIP-Trend study participants using the AbsoluteIDQ p180 Kit.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive symptom; Depressive symptom; Depressive symptom;

Criteria for depression

At least 2 of the PHQ-9 questions had been answered with at least “more than half of the days” in the past two weeks

Sample size

2379

Tissue

Peripheral; Blood; Serum;

Peripheral; Blood; Plasma;

Platform

MS-based; GC-MS: not reported;

MS-based; LC-MS: not reported;

MS-based; LC-MS: MAT-95 double-focusing magnetic/electric sector mass spectrometer ultra-high performance liquid chromatography/tandem MS (UHPLC/MS/MS; Thermo Scientific, USA);

PMID

34088979

DOI

10.1038/s41380-021-01176-0

Citation

Zacharias HU, Hertel J, Johar H, et al. A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression. Mol Psychiatry. 2021 Jun 4.

Metabolite

Dodecanoylcarnitine;